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It was recently shown that the major genetic risk factor associated
with becoming severely ill with COVID-19 when infected by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is inherited
from Neandertals. New, larger genetic association studies now allow
additional genetic risk factors to be discovered. Using data from the
Genetics of Mortality in Critical Care (GenOMICC) consortium, we
show that a haplotype at a region on chromosome 12 associatedwith
requiring intensive carewhen infectedwith the virus is inherited from
Neandertals. This region encodes proteins that activate enzymes that
are important during infections with RNA viruses. In contrast to the
previously described Neandertal haplotype that increases the risk for
severe COVID-19, this Neandertal haplotype is protective against se-
vere disease. It also differs from the risk haplotype in that it has a
more moderate effect and occurs at substantial frequencies in all re-
gions of the world outside Africa. Among ancient human genomes in
western Eurasia, the frequency of the protective Neandertal haplo-
type may have increased between 20,000 and 10,000 y ago and again
during the past 1,000 y.
Neandertals | COVID-19 | OAS1 | SARS-CoV-2
Neandertals evolved in western Eurasia about half a millionyears ago and subsequently lived largely separated from the
ancestors of modern humans in Africa (1), although limited gene
flow from Africa is likely to have occurred (2–5). Neandertals as
well as Denisovans, their Asian sister group, then became extinct
about 40,000 y ago (6). However, they continue to have a bio-
logical impact on human physiology today through genetic con-
tributions to modern human populations that occurred during
the last tens of thousands of years of their existence (e.g., refs.
7–10).
Some of these contributions may reflect adaptations to envi-
ronments outside Africa where Neandertals lived over several
hundred thousands of years (11). During this time, they are likely
to have adapted to infectious diseases, which are known to be
strong selective factors that may, at least partly, have differed
between sub-Saharan Africa and Eurasia (12). Indeed, several
genetic variants contributed by archaic hominins to modern hu-
mans have been shown to affect genes involved in immunity (e.g.,
refs. 7, 8, 13, 14). In particular, variants at several loci containing
genes involved in innate immunity come from Neandertals and
Denisovans (15), for example, toll-like receptor gene variants
which decrease the susceptibility to Helicobacter pylori infections
and the risk for allergies (16). Furthermore, proteins interacting
with RNA viruses have been shown to be encoded by DNA re-
gions introgressed from Neandertals more often than expected
(17), and RNA viruses might have driven many adaptive events in
humans (18).
Recently, it was shown that a haplotype in a region on chromo-
some 3 is associated with becoming critically ill upon infection with
the novel severe acute respiratory coronavirus 2 (SARS-CoV-2)
(19) and was contributed to modern humans by Neandertals (20).
Each copy of this haplotype approximately doubles the risk of its
carriers requiring intensive care when infected by SARS-CoV-2. It
reaches carrier frequencies of up to ∼65% in South Asia and ∼16%
in Europe, whereas it is almost absent in East Asia. Thus, although
this haplotype is detrimental for its carriers during the current
pandemic, it may have been beneficial in earlier times in South Asia
(21), perhaps by conferring protection against other pathogens,
whereas it may have been eliminated in East Asia by negative
selection.
A new study from the Genetic of Mortality in Critical Care
(GenOMICC) consortium, which includes 2,244 critically ill
COVID-19 patients and controls (22), recently became available.
In addition to the risk locus on chromosome 3, it identifies seven
loci with genome-wide significant effects located on chromo-
somes 6, 12, 19, and 21. Here, we show that, at one of these loci,
a haplotype associated with reduced risk of becoming severely ill
upon SARS-CoV-2 infection is derived from Neandertals.
Results and Discussion
A Neandertal Haplotype on Chromosome 12.We investigated whether
the index single-nucleotide polymorphisms (SNPs), that is, the
SNPs with the strongest association (Materials and Methods), at
the seven loci associated with risk of requiring intensive care upon
SARS-CoV-2 infection on chromosomes 6, 12, 19, and 21 (22)
harbor Neandertal-like alleles. To this end, we required that one
of the alleles of the index SNPs should match all three high-quality
Neandertals genomes, while being absent in the genomes of 108
African Yoruba individuals [r2 > 0.80; the 1000 Genomes Project
(23)]. None of the index SNPs for the loci on chromosomes 6, 19,
and 21 fulfilled these criteria, whereas the locus on chromosome
12 did.
To further investigate this locus, we used data from the
COVID-19 Host Genetics Initiative [HGI; round 4 (24)]. We find
that the SNPs in the chromosome 12 locus associated with
COVID-19 hospitalization (P < 1.0e-5; Fig. 1) are in linkage
disequilibrium (LD) (r2 ≥ 0.8) in Europeans and form a haplotype
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of ∼75 kb (chr12: 113,350,796 to 113,425,679; hg19). LD to the
index SNP of the GenOMICC study is given in SI Appendix, Table
S1. Haplotypes of this length carrying alleles absent in Yoruba but
present in Neandertals are likely to have been introduced into
the gene pool of modern humans due to interbreeding with
Neandertals (25).
To test whether the 75-kb haplotype is the result of gene flow
from Neandertals, we analyzed its relationship to present-day
and archaic genomes. To do this, we used the haplotypes seen
more than 10 times among the individuals in the 1000 Genomes
Project (23) and the genome sequences of a ∼70,000-y-old Ne-
andertal from Chagyrskaya Cave in southern Siberia (26), a
∼50,000-y-old Neandertal from Vindija Cave in Croatia (27), a
∼120,000-y-old Neandertal from Denisova Cave in southern
Siberia (1), and a ∼80,000-y-old Denisovan individual from the
same site (28). Fig. 2 shows a phylogenetic tree estimating the
relationships among these haplotypes. Among the 64 modern
human haplotypes, eight form a monophyletic group with the
three Neandertal sequences.
Genomic segments with similarity to Neandertal genomes may
either derive from common ancestors of the two groups that lived
about half a million years ago or be contributed by Neandertals to
modern humans by mixing between the two groups when they met
less than 100,000 y ago (25). To test whether a segment of 75 kb
may have survived in this region of the genome since the common
ancestor of the groups without being broken down by recombi-
nation that affects chromosomes in each generation, we use a
published equation (29), a generation time of 29 y (30), a regional
recombination rate of 0.80 cM/Mb (31), and a split time between
Neandertals and modern humans of 550,000 y (1) followed by
interbreeding ∼50,000 y ago. Under these assumptions, in this
region, segments of length 16.3 kb or longer are not expected to
derive from the population ancestral to Neandertals and modern
humans (P = 0.05), making it highly unlikely that a 75-kb haplo-
type does so (P = 8.2e-9). We thus conclude that the haplotype
entered the human gene pool from Neandertals. In agreement
with this, a previous study (32) has described gene flow from
Neandertals in this genomic region.
COVID-19 Protection and Geographic Distribution. We find that the
index variant of the protective haplotype in the GenOMICC study
(rs10735079, P = 1.7e-8) matches all three Neandertal genomes
available. The relative risk of needing intensive care is reduced by
∼22% per copy of the Neandertal haplotype (under the rare disease
assumption, odds ratio [OR] = 0.78, 95% CI 0.71 to 0.85). As
expected given the phylogeny (Fig. 2), almost all of the alleles
cosegregating with the protective allele of the index SNP are found
in the Neandertal genomes (34 of 35 called SNPs; see SI Appendix,
Table S2, which, in contrast to Fig. 1, includes data contributed by
23andMe to HGI).
Today, the haplotype is almost completely absent in African
populations south of the Sahara but exists at frequencies of ∼25 to
30% in most populations in Eurasia (Fig. 3). In the Americas, it
occurs in lower frequencies in some populations of African ancestry,
presumably due to gene flow from populations of European or
Native American ancestry (33).
Putative Functional Variants. The Neandertal haplotype protective
against severe COVID-19 on chromosome 12 contains parts or all
of the three genes OAS1, OAS2, and OAS3, which encode oligoa-
denylate synthetases. These enzymes are induced by interferons and
activated by double-stranded RNA. They produce short-chain pol-
yadenylates, which, in turn, activate ribonuclease L, an enzyme that
degrades intracellular double-stranded RNA and activates other
antiviral mechanisms in cells infected by viruses (reviewed by
ref. 34).
To investigate which of these genes might be involved in pro-
tection against severe COVID-19, we plot the genomic location of
Fig. 1. Genetic variants associated with COVID-19 hospitalization at the
OAS locus. Variants marked in red have P values less than 1e-5. In Europeans,
they are in LD with the index variant (r2 ≥ 0.8), forming a haplotype (black
bar) with the genomic coordinates chr12: 113,350,796 to 113,425,679. P
values are from the HGI (24), excluding the 23andMe data for which only
sparse SNP data are available. The x axis gives hg19 coordinates; genes in the
region are indicated below. The three OAS genes are transcribed from left to
right. Yellow dots indicate rs10735079 (right, the GenOMICC index SNP) and
rs1156361 (left, typed by the Human Origins Array).
Fig. 2. Phylogeny relating DNA sequences associated with COVID-19 severity
on chromosome 12. Haplotypes from three Neandertal genomes, the Deni-
sovan genome, and haplotypes seen more than 20 times in individuals in the
1000 Genomes Project are included. The colored area indicates haplotypes that
carry the protective allele at rs1156361. The tree is rooted with the inferred
ancestral sequence from Ensembl (46). Six heterozygous positions in the ar-
chaic genomes were excluded. Haplotypes XXIX and XXX are partially made
up of Neandertal-like DNA sequences due to recombination events.
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the OAS genes below the P values for the SNPs associated with
severe COVID-19 (Fig. 1). While the association (P < 1.0e-5)
overlaps all three OAS genes, the SNPs with the most significant
associations (P < 5.0e-8) are in OAS3. However, the high level of
LD and stochasticity in the associations make any conclusion re-
garding causality based on P values tenuous.
Nevertheless, there are alleles on the Neandertal haplotype
which stand out as potentially functionally important. One SNP
(rs10774671) has been described as affecting a splice acceptor
site in OAS1 (35). The derived allele at this SNP, which is the
most frequent allele in present-day humans, alters splicing of
OAS1 transcript such that several protein isoforms are produced
instead of the ancestral isoform which is preserved in Neander-
tals (p46) (36). The latter, Neandertal-like isoform has higher
enzymatic activity than the derived isoforms common in modern
humans (37). Outside Africa, the ancestral allele is present only
in the context of the Neandertal haplotype, whereas, in Africa, it
exists independently of this haplotype, presumably as a genetic
variant inherited from the common ancestors of modern humans
and Neandertals that was lost in modern human populations that
left Africa (35).
In addition to the splice acceptor site, the Neandertal haplotype
contains a missense variant (rs2660) in OAS1, a missense variant
(rs1859330) and two synonymous variants (rs1859329 and
rs2285932) in OAS3, and a missense variant in OAS2 (rs1293767).
Three of these Neandertal-like variants are ancestral and occur in
Africa (rs2660, rs1859330, and rs1859329), whereas two are derived
in Neandertals (rs2285932 and rs1293767).
Several SNPs on the chromosome 12 haplotype have previously
been studied with respect to their effects on other viral infections.
The Neandertal-like splice acceptor variant has been associated
with protection against West Nile Virus (rs10774671, OR = 0.63,
95% CI 0.5–0.83) (38), and the Neandertal-like haplotype has
been associated with increased resistance to hepatitis C infections
(39). Notably, the Neandertal missense variant in OAS1 (rs2660)
(or variants in LD with this variant) has been shown to be asso-
ciated with moderate to strong protection against SARS-CoV
[OR = 0.42, 95% CI: 0.20 to 0.89 (40)], although this study was
limited in numbers of cases and controls. The SARS-CoV is
closely related to SARS-CoV-2, emerged in 2003, and caused a
mortality rate of ∼9% among infected individuals of all ages, and
much higher rates of fatalities in older individuals (41). Finally, the
Fig. 3. Geographic distribution of the allele indicative of the Neandertal haplotype protective against severe COVID-19. Pie charts indicate minor allele
frequency in red at rs1156361. Frequency data are from the 1000 Genomes Project (23). Map source data are from OpenStreetMap.
Fig. 4. Frequencies across time of two Neandertal haplotypes associated with COVID-19 severity. Frequencies for rs1156361 at the OAS locus on chromosome
12 (A) and rs10490770 at the chromosome 3 locus (B). Error bars indicate SE (Wilson scores). Time periods are indicated in years before present (bp). Ancient
data are from a compiled dataset (42), and present-day data are from the 1000 Genomes Project (23).
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Neandertal versions of the OAS genes are expressed differently in
response to different viral infections in cells in tissue culture in
terms of both expression levels and splice forms (35).
Haplotype Frequencies across Time. During the past few years,
genome-wide data from thousands of prehistoric humans have
been generated and compiled (42). This makes it possible to begin
to directly gauge how frequencies of genetic variants have changed
over time. Although this approach is still limited by the relatively
small numbers of individuals and geographic regions for which
data are available, we apply it here for the two Neandertal-derived
haplotypes that affect the clinical outcomes upon infection with
SARS-CoV-2.
To tag the Neandertal OAS haplotype on chromosome 12, we
use an SNP (rs1156361) that carries a derived Neandertal-like
allele, is associated with the index variant of the GenOMICC
study (r2 = 0.99 in Eurasia), and is typed by the Affymetrix Human
Origins array used to study the majority of ancient human ge-
nomes used here (42). Although this analysis is limited in that it
tracks a single tag SNP, the fact that it is derived on the Nean-
dertal lineage and in LD with the Neandertal haplotype makes this
analysis feasible. We restrict the analysis to Eurasia and divide the
data into five time windows that vary between 20,000 and 2,000 y
in length, to balance the number of genomes available while still
allowing potential differences in frequency to be discerned.
Fig. 4A shows that the Neandertal OAS haplotype seems to have
occurred at frequencies below 10% prior to 20,000 y ago. Between
20,000 and 10,000 y ago, the allele frequency was in the order of
15%. Subsequently, it seems to have been present at frequencies at
or slightly below 20% until 3,000 y to 1,000 y ago. Intriguingly, the
current allele frequency in Eurasia is ∼30%, suggesting that the
NeandertalOAS haplotype may have increased in frequency relatively
recently.
To similarly estimate the frequency of the Neandertal risk
haplotype on chromosome 3 (20), we use the SNP rs10490770 that
fulfills the criteria applied above for the chromosome 12 haplo-
type (Fig. 4B). Prior to 20,000 y ago, we find no carrier of the risk
haplotype among 16 genomes available. Among individuals who
lived between 20,000 and 10,000 y ago and later, the haplotype is
present in ∼10% until today, when it occurs at a frequency of
∼12.5%. Thus, similar to the OAS locus, the Neandertal chro-
mosome 3 locus, the frequency seems to be lower in the period
prior to 20,000 y ago than in the later periods. However, the data
are still scarce, making this observation preliminary. In contrast to
the OAS locus, there is no indication of any increase in the fre-
quency of the Neandertal haplotype on chromosome 3 in
historical times.
We caution that the prehistoric data available are heavily bi-
ased toward western Eurasia and are still sparse, particularly for
older periods. However, additional data from ancient human
remains are rapidly being generated, making us confident that it
will soon be possible to identify loci that may have been the
targets of positive and negative selection, by studying allele fre-
quencies over time in certain geographical regions while cor-
recting for migration events that caused genome-wide shifts in
allele frequencies.
Despite theses caveats, it is interesting that the Neandertal-
derived OAS locus has recently increased in frequency in Eura-
sia. This is compatible with previous work on the variation
among present-day populations (32, 35, 43) suggesting that this
locus has been positively selected. It is also compatible with
Denisovans having contributed a version of this locus, which
carries ancestral variants, for example, at the slice acceptor site
(rs10774671), to people in Oceania, where it occurs at substan-
tial frequencies today (44).
Conclusions. A Neandertal haplotype on chromosome 12 is pro-
tective for severe disease in the current SARS-CoV-2 pandemic.
It is present in populations in Eurasia and the Americas at car-
rier frequencies that often reach and exceed 50%. The ancestral
Neandertal OAS locus variants may thus have been advanta-
geous to modern humans throughout Eurasia, perhaps due to
one or many epidemics involving RNA viruses, especially given
that the Neandertal haplotype has been found to be protective
for at least three RNA viruses (West Nile virus, hepatitis C virus,
SARS-CoV). Supporting this notion, simulations have demon-
strated that the Neandertal OAS haplotype has been under
positive selection in modern humans (35). Strikingly, the OAS1
protein encoded by the modern human OAS haplotype is of
lower enzymatic activity than the one encoded by the Neandertal
haplotype (37). This may have been advantageous at some point
in Africa, because loss-of-function mutations of the OAS1 locus
have occurred numerous times among primates (45), suggesting
that the maintenance of OAS1 activity is costly to an organism.
One may speculate that, when modern humans encountered new
RNA viruses outside Africa, the higher enzymatic activity of the
ancestral variants that they acquired through genetic interactions
with Neandertals may have been advantageous.
Intriguingly, there is evidence that the Neandertal-like OAS
haplotype may have recently increased in frequency in Eurasia
(Fig. 4A), suggesting that selection may have positively affected the
Neandertal-derived OAS locus in the last millennium. Future
studies of human remains from historical times will clarify whether,
and when, this occurred.
Materials and Methods
The index variants for the seven novel loci (rs9380142, rs143334143, rs3131294,
rs10735079, rs74956615, rs2109069, and rs2236757) were obtained from
GenOMICC (22). The regional summary statistics from the round 4 release of
the metaanalysis carried out by the COVID-19 HGI (24) (https://covid19hg.org/
results) was used to analyze the chromosome 12 locus (hospitalized vs. pop-
ulation controls, i.e., “B2” phenotype, using all ancestries but not including the
23andMe study, due to limited release of number of variants). LD was calcu-
lated using LDlink 4.1, and alleles were compared to the archaic genomes
using tabix (HTSlib 1.10). The haplotype associated with protection against
severe COVID-19 was investigated using phylogenetic software (PhyML 3.0),
and the probability of observing a haplotype of a certain length or longer due
to incomplete lineage sorting was calculated as described (29). The present-
day haplotypes were constructed by including all variable positions in the re-
gion chr12: 113,350,796 to 113,425,679, excluding singletons. Haplotypes seen
more than 10 times were included in the phylogenetic analysis. The inferred
ancestral states at variable positions among present-day humans were taken
from Ensembl. Genotypes of ancient genomes of modern humans were
obtained from a compiled database (42). Maps displaying allele frequencies of
different populations were made using Mathematica 11.0 (Wolfram Research,
Inc.) and OpenStreetMap data.
Data Availability.. Previously published data were used for this work (COVID-19
HGI 1000 Genomes Project).
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